XERS is currently covered by 1 analysts with average potential upside of $4.9 (111.95%) backed by 1 price targets and 5 ratings. Documented since 17-Jul-2018. Analyst's average stock valuation to be materialised ratio is 50% with an average time for price targets to be met of 18.5 days.
Most recent stock forecast was given by OREN LIVNAT from HCWAINWRIGHT on 09-Mar-2023.
Highest price target for XERS is 3, Lowest price target is 1, average price target is 2.
Currently, out of the existing stock ratings of XERS - 2 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
6
$4.72 (368.75%)
5.4
18 days ago
0/3 (0%)
$3.08 (189.12%)
Buy
26
4 years 4 months 18 days ago
1/1 (100%)
$6.71 (34.78%)
37
What is XERS(Xeris Pharmaceuticals, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on XERS(Xeris Pharmaceuticals, Inc) with a proven track record?
